Modified-chitosan/siRNA nanoparticles downregulate cellular CDX2 expression and cross the gastric mucus barrier.
Development of effective non-viral vectors is of crucial importance in the implementation of RNA interference in clinical routine. The localized delivery of siRNAs to the gastrointestinal mucosa is highly desired but faces specific problems such as the stability in gastric acidity conditions and the...
Main Authors: | Ana Sadio, Jenny K Gustafsson, Bruno Pereira, Carla Pereira Gomes, Gunnar C Hansson, Leonor David, Ana Paula Pêgo, Raquel Almeida |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4055692?pdf=render |
Similar Items
-
Targeted gene delivery to the brain using CDX-modified chitosan nanoparticles
by: Tina Sepasi, et al.
Published: (2023-03-01) -
Dynamic changes in mucus thickness and ion secretion during Citrobacter rodentium infection and clearance.
by: Jenny K Gustafsson, et al.
Published: (2013-01-01) -
In Vitro Cellular Uptake and Transfection of Oligoarginine-Conjugated Glycol Chitosan/siRNA Nanoparticles
by: Eun-Ju Jeong, et al.
Published: (2021-12-01) -
Proteome of airway surface liquid and mucus in newborn wildtype and cystic fibrosis piglets
by: Ana M. Rodriguez-Piñeiro, et al.
Published: (2023-03-01) -
Data-Driven Modeling of the Cellular Pharmacokinetics of Degradable Chitosan-Based Nanoparticles
by: Huw D. Summers, et al.
Published: (2021-10-01)